Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development
Authors:
- 17 November 2015
- journal article
- Published by Springer Nature in Tumor Biology
- Vol. 37 (4) , 5621-5632
Abstract
MiRNAs regulate gene expression and play pivotal roles in biological processes. MiRNAs can be inactivated by epigenetic mechanisms, such as DNA hypermethylation of CpG sites within CpG islands. Here, we investigated the role and methylation status of miR-203a and miR-203b in esophageal cancer cell lines and primary esophageal squamous cell carcinoma (ESCC) tumors and further elucidate the role of both miRNAs in the prognosis of ESCC. The present study revealed a strong downregulation of miR-203a and miR-203b in esophageal cancer cell lines and primary ESCC samples. Treatment of esophageal cancer cells with demethylating agent 5-Aza-dC led to increased miR-203a and miR-203b expression, confirming the epigenetic regulation of both miRNAs. The inhibition of proliferation and invasiveness in esophageal cancer cells after treated with 5-Aza-dC or transfected with miR-203a or miR-203b mimics, suggesting the tumor suppressor role of both miRNAs in esophageal cancer. Furthermore, the critical CpG sites of miR-203a and miR-203b were found to be located in proximal promoter region, and the proximal promoter hypermethylation of both miRNAs was found to influence transcriptional activity. Downregulation and hypermethylation of miR-203a and miR-203b were associated with TNM stage, pathological differentiation, and lymph node metastasis. ESCC patients in stages III and IV, with reduced expression of miR-203a or hypermethylation of miR-203a or miR-203b, demonstrated poor patient survival. In summary, our results suggest that miR-203a and miR-203b may function as tumor-suppressive miRNAs that are inactivated through proximal promoter hypermethylation and miR-203a expression and methylation may be useful prognostic marker in ESCC patients.Keywords
This publication has 50 references indexed in Scilit:
- Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagusDiagnostic Pathology, 2015
- Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203Cellular Immunology, 2014
- Hypermethylation of miR-203 in endometrial carcinomasGynecologic Oncology, 2014
- MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumoursTumor Biology, 2014
- miR-203, a Tumor Suppressor Frequently Down-regulated by Promoter Hypermethylation in RhabdomyosarcomaJournal of Biological Chemistry, 2014
- Upregulation of microRNA-203 is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancerMedical Oncology, 2013
- MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cellsJournal of Experimental & Clinical Cancer Research, 2012
- Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAomeHuman Molecular Genetics, 2011
- MicroRNA-203 Expression as a New Prognostic Marker of Pancreatic AdenocarcinomaAnnals of Surgical Oncology, 2010
- MicroRNAs: Key players in carcinogenesis and novel therapeutic targetsEuropean Journal of Surgical Oncology, 2009